BHC - Bausch Health Companies Inc
(NaN%)
Sell
Weak Growth●Earnings/Profit is Negative
12%
based on last 5 year data.
Income Statement is WEAK
Revenue Growth is -6.67%
Operating Income turning Positive
Net Income is Negative but improving
Earnings Per Share (EPS) is Negative but improving
Net Margin is -6.98%
Balance Sheet is WEAK
Current Asset to Current Liability Ratio is 1.09
Debt Ratio is 0.98
Current Debt to Net Income Ratio not available
Total Debt to Total Assets Ratio is 0.78
Cash Flow is WEAK
Cash from Operations Growth is -25.98%
Capital Expenditure not available
Net Increase in Cash is Negative
Long Term Score Trend is NEUTRAL
Investment Risk is High
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Bausch Health Companies Inc (BHC) - https://www.bauschhealth.com
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.Exchange - NEW YORK STOCK EXCHANGE, INC.
Industry - Pharmaceutical Preparation Manufacturing
Sector - Manufacturing
CEO -
Employees - 21,100
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.
Know the Stock © 2021 and future.